<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>IAP, a type of alpha 1-acid <z:chebi fb="2" ids="17089">glycoprotein</z:chebi>, is mainly produced by macrophages when stimulated in the presence of circulating immune complexes or some inflammatory substances </plain></SENT>
<SENT sid="1" pm="."><plain>We assayed the serum levels of IAP by a single radial immunodiffusion method </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:mpath ids='MPATH_458'>normal</z:mpath> level of IAP is below 500 micrograms/ml (385 +/- 73) </plain></SENT>
<SENT sid="3" pm="."><plain>In multiple <z:mp ids='MP_0000612'>sclerosis</z:mp> patients, however, IAP increased during exacerbation (630 +/- 191) and decreased during the inactive stage (433 +/- 170) </plain></SENT>
<SENT sid="4" pm="."><plain>Eighty-five percent of patients with neuro-<z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's disease</z:e> also had high levels of IAP, correlating well with disease activity </plain></SENT>
<SENT sid="5" pm="."><plain>In some patients with <z:e sem="disease" ids="C0018378" disease_type="Disease or Syndrome" abbrv="">Guillain-Barr√© syndrome</z:e> or <z:e sem="disease" ids="C0393799" disease_type="Disease or Syndrome" abbrv="">Miller Fisher syndrome</z:e>, IAP increased during the <z:hpo ids='HP_0011009'>acute</z:hpo> phase </plain></SENT>
<SENT sid="6" pm="."><plain>In patients with <z:e sem="disease" ids="C0019348" disease_type="Disease or Syndrome" abbrv="">herpes simplex</z:e> <z:hpo ids='HP_0002383'>encephalitis</z:hpo>, IAP levels remained abnormally high for more than 60 days after <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>The mean value of IAP in patients with <z:hpo ids='HP_0007354'>amyotrophic lateral sclerosis</z:hpo> did not differ from that of <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="8" pm="."><plain>An increase in IAP in the serum of patients seems to reflect the activity of an inflammatory or immunopathological process </plain></SENT>
</text></document>